Daily Eating Patterns and Their Impact on Health and Disease

Trends in Endocrinology and Metabolism

Volumn 27, Issue 2, 2016, Pages 69-83

  Zarrinpar, Amir ^a,b   Chaix, Amandine ^a   Panda, Satchidananda ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Dyssynchrony; Eating; Entrainment; Fasting; Gut; Hepatic; High fat diet; Liver; Microbiome; Oscillation; Time restricted feeding; Transcriptome

Indexed keywords

CALORIC RESTRICTION; CIRCADIAN RHYTHM; DISEASE PREDISPOSITION; EATING HABIT; FEEDING; GENETIC MANIPULATION; HUMAN; LIGHT DARK CYCLE; METABOLIC DISORDER; NONHUMAN; NUTRITION; OBESITY; PANDEMIC; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; ANIMAL; DISEASE; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; HEALTH; PHYSIOLOGY; SLEEP;

ANIMALS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; DISEASE; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; HEALTH; HUMANS; SLEEP;

EID: 84958887725     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.11.007     Document Type: Review

References (121)

1. Ogden C.L., et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. J. Am. Med. Assoc. 2014, 311:806-814.
2. Finkelstein E.A., et al. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. 2009, 28:w822-w831.
3. Casazza K., et al. Myths, presumptions, and facts about obesity. N. Engl. J. Med. 2013, 368:446-454.
4. Levi J., et al. The State of Obesity: Better Policies for a Healthier America 2014 2014, Trust for America's Health.
5. Gerhart-Hines Z., Lazar M.A. Circadian metabolism in the light of evolution. Endocr. Rev. 2015, 36:289-304.
6. Bass J. Circadian topology of metabolism. Nature 2012, 491:348-356.
7. van Cauter E. Endocrine rhythms. Principles and Practice of Endocrinology and Metabolism 2001, 57-68. Lippincott Williams & Wilkins. 3rd edn. K.L. Becker (Ed.).
8. Nicolaides N.C., et al. Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions. Ann. N. Y. Acad. Sci. 2014, 1318:71-80.
9. Nohara K., et al. Manipulating the circadian and sleep cycles to protect against metabolic disease. Front. Endocrinol. 2015, 6:35.
10. Franken P., Dijk D.J. Circadian clock genes and sleep homeostasis. Eur. J. Neurosci. 2009, 29:1820-1829.
11. Welsh D.K., et al. Suprachiasmatic nucleus: cell autonomy and network properties. Annu. Rev. Physiol. 2010, 72:551-577.
12. Mure L.S., Panda S. Fear of the light or need for action: the IGL will judge. Neuron 2012, 75:546-548.
13. von Ruesten A., et al. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS ONE 2012, 7:e30972.
14. Liu Y., et al. Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 Behavioral Risk Factor Surveillance System. Sleep 2010, 36:1421-1427.
15. Spiegel K., et al. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat. Rev. Endocrinol. 2009, 5:253-261.
16. Siegel J.M. Clues to the functions of mammalian sleep. Nature 2005, 437:1264-1271.
17. Morris C.J., et al. Circadian system, sleep and endocrinology. Mol. Cell. Endocrinol. 2012, 349:91-104.
18. Reiter R.J. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp. Gerontol. 1995, 30:199-212.
19. Wright K.P., et al. Entrainment of the human circadian clock to the natural light-dark cycle. Curr. Biol. 2013, 23:1554-1558.
20. Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 2012, 74:246-260.
21. Van Cauter E., et al. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev. 1997, 18:716-738.
22. Zhou B., et al. CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1. Hepatology 2014, 59:2196-2206.
23. Reddy A.B., O'Neill J.S. Healthy clocks, healthy body, healthy mind. Trends Cell Biol. 2010, 20:36-44.
24. Zhang R., et al. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:16219-16224.
25. Panda S., et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002, 109:307-320.
26. Storch K.F., et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002, 417:78-83.
27. Asher G., Schibler U. Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metab. 2011, 13:125-137.
28. Vollmers C., et al. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21453-21458.
29. Asher G., Sassone-Corsi P. Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock. Cell 2015, 161:84-92.
30. Lamia K.A., et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 2009, 326:437-440.
31. O'Neill J.S., et al. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 2008, 320:949-953.
32. Adamovich Y., et al. Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides. Cell Metab. 2014, 19:319-330.
33. Arble D.M., et al. Circadian disruption and metabolic disease: findings from animal models. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24:785-800.
34. Kalsbeek A., et al. Circadian control of glucose metabolism. Mol. Metab. 2014, 3:372-383.
35. Rudic R.D., et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2004, 2:e377.
36. Marcheva B., et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010, 466:627-631.
37. Cho H., et al. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta. Nature 2012, 485:123-127.
38. Liu Z., et al. PER1 phosphorylation specifies feeding rhythm in mice. Cell Rep. 2014, 7:1509-1520.
39. Kohsaka A., et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007, 6:414-421.
40. Mendoza J., et al. High-fat feeding alters the clock synchronization to light. J. Physiol. 2008, 586:5901-5910.
41. Ando H., et al. Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 2011, 152:1347-1354.
42. Ho A., Chin A. Circadian feeding and drinking patterns of genetically obese mice fed solid chow diet. Physiol. Behav. 1988, 43:651-656.
43. Salgado-Delgado R., et al. Internal desynchronization in a model of night-work by forced activity in rats. Neuroscience 2008, 154:922-931.
44. Fonken L.K., et al. Light at night increases body mass by shifting the time of food intake. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18664-18669.
45. Damiola F., et al. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000, 14:2950-2961.
46. Arble D.M., et al. Circadian timing of food intake contributes to weight gain. Obesity 2009, 17:2100-2102.
47. Lopez-Guimera G., et al. CLOCK 3111 T/C SNP interacts with emotional eating behavior for weight-loss in a Mediterranean population. PLoS ONE 2014, 9:e99152.
48. Scott E.M., et al. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int. J. Obes. 2008, 32:658-662.
49. Sookoian S., et al. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am. J. Clin. Nutr. 2008, 87:1606-1615.
50. McMenamin T.M. A time to work: recent trends in shift work and flexible schedules. Mon. Labor Rev. 2007, 130:3-15.
51. Canuto R., et al. Metabolic syndrome and shift work: a systematic review. Sleep Med. Rev. 2013, 17:425-431.
52. van Drongelen A., et al. The effects of shift work on body weight change - a systematic review of longitudinal studies. Scand. J. Work Environ. Health 2011, 37:263-275.
53. Wang F., et al. Meta-analysis on night shift work and risk of metabolic syndrome. Obes. Rev. 2014, 15:709-720.
54. Brum M.C., et al. Shift work and its association with metabolic disorders. Diabetol. Metab. Syndr. 2015, 7:45.
55. Sookoian S., et al. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. J. Intern. Med. 2007, 261:285-292.
56. Fujino Y., et al. A prospective cohort study of shift work and risk of ischemic heart disease in Japanese male workers. Am. J. Epidemiol. 2006, 164:128-135.
57. Bose M., et al. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Curr. Opin. Endocrinol. Diab. Obes. 2009, 16:340-346.
58. McHill A.W., et al. Impact of circadian misalignment on energy metabolism during simulated nightshift work. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:17302-17307.
59. Scheer F.A., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4453-4458.
60. Gill S., Panda S. A smartphone app reveals erratic diurnal eating patterns in humans that can be modulated for health benefits. Cell Metab. 2015, 22:789-798.
61. Hatori M., et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012, 15:848-860.
62. Sherman H., et al. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 2012, 26:3493-3502.
63. Zarrinpar A., et al. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 2014, 20:1006-1017.
64. Tsai J.Y., et al. Influence of dark phase restricted high fat feeding on myocardial adaptation in mice. J. Mol. Cell. Cardiol. 2013, 55:147-155.
65. Chaix A., et al. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014, 20:991-1005.
66. Gill S., et al. Time-restricted feeding attenuates age-related cardiac decline in Drosophila. Science 2015, 347:1265-1269.
67. Mattson M.P., et al. Meal frequency and timing in health and disease. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:16647-16653.
68. Garaulet M., et al. Timing of food intake predicts weight loss effectiveness. Int. J. Obes. 2013, 37:604-611.
69. Jakubowicz D., et al. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity 2013, 21:2504-2512.
70. Zarrinpar A., Loomba R. Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2012, 36:909-921.
71. Bechtold D.A., Loudon A.S. Hypothalamic clocks and rhythms in feeding behaviour. Trends Neurosci. 2013, 36:74-82.
72. Scheving L.A. Biological clocks and the digestive system. Gastroenterology 2000, 119:536-549.
73. Duca F.A., et al. Glucoregulatory relevance of small intestinal nutrient sensing in physiology, bariatric surgery, and pharmacology. Cell Metab. 2015, 22:367-380.
74. Nohr M.K., et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 2013, 154:3552-3564.
75. Kimura I., et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 2013, 4:1829.
76. Samuel B.S., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16767-16772.
77. + salvage pathway by CLOCK-SIRT1. Science 2009, 324:654-657.
78. + biosynthesis. Science 2009, 324:651-654.
79. + cycle drives mitochondrial oxidative metabolism in mice. Science 2013, 342:1243417.
80. Miller-Fleming L., et al. Remaining mysteries of molecular biology: the role of polyamines in the cell. J. Mol. Biol. 2015, 427:3389-3406.
81. Zwighaft Z., et al. Circadian clock control by polyamine levels through a mechanism that declines with age. Cell Metab. 2015, 22:874-885.
82. Gil-Lozano M., et al. Circadian secretion of the intestinal hormone GLP-1 by the rodent L cell. Diabetes 2014, 63:3674-3685.
83. Shah M., Vella A. Effects of GLP-1 on appetite and weight. Rev. Endocr. Metab. Disord. 2014, 15:181-187.
84. Ding X., et al. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 2006, 43:173-181.
85. Liu Y., et al. Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease. World J. Gastroenterol. 2014, 20:9090-9097.
86. Matsubara T., et al. FXR signaling in the enterohepatic system. Mol. Cell. Endocrinol. 2013, 368:17-29.
87. Cicione C., et al. Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology 2012, 56:2404-2411.
88. Pols T.W., et al. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J. Hepatol. 2011, 54:1263-1272.
89. Watanabe M., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
90. Katsuma S., et al. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 2005, 329:386-390.
91. Zhang Y.K., et al. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters. PLoS ONE 2011, 6:e16683.
92. Greiner T., Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol. Metab. 2011, 22:117-123.
93. Thaiss C.A., et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 2014, 159:514-529.
94. Leone V., et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe 2015, 17:681-689.
95. Liang X., et al. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:10479-10484.
96. Mukherji A., et al. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013, 153:812-827.
97. Voigt R.M., et al. Circadian disorganization alters intestinal microbiota. PLoS ONE 2014, 9:e97500.
98. Henao-Mejia J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
99. Everard A., Cani P.D. Gut microbiota and GLP-1. Rev. Endocr. Metab. Disord. 2014, 15:189-196.
100. De Vadder F., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014, 156:84-96.
101. Sayin S.I., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013, 17:225-235.
102. Schulz M.D., et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 2014, 514:508-512.
103. Bugge A., et al. Rev-erbalpha and Rev-erbbeta coordinately protect the circadian clock and normal metabolic function. Genes Dev. 2012, 26:657-667.
104. Delezie J., et al. The nuclear receptor REV-ERBalpha is required for the daily balance of carbohydrate and lipid metabolism. FASEB J. 2012, 26:3321-3335.
105. Lamia K.A., et al. Physiological significance of a peripheral tissue circadian clock. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15172-15177.
106. Grimaldi B., et al. PER2 controls lipid metabolism by direct regulation of PPARgamma. Cell Metab. 2010, 12:509-520.
107. Schmutz I., et al. The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors. Genes Dev. 2010, 24:345-357.
108. Zhao Y., et al. Loss of mPer2 increases plasma insulin levels by enhanced glucose-stimulated insulin secretion and impaired insulin clearance in mice. FEBS Lett. 2012, 586:1306-1311.
109. L expression. Mol. Metab. 2013, 2:292-305.
110. Ikeda H., et al. Clock gene defect disrupts light-dependency of autonomic nerve activity. Biochem. Biophys. Res. Commun. 2007, 364:457-463.
111. Lamia K.A., et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 2011, 480:552-556.
112. Barclay J.L., et al. High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E1053-E1063.
113. Shimba S., et al. Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS ONE 2011, 6:e25231.
114. Paschos G.K., et al. Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat. Med. 2012, 18:1768-1777.
115. Shi S.Q., et al. Circadian disruption leads to insulin resistance and obesity. Curr. Biol. 2013, 23:372-381.
116. Kennaway D.J., et al. Global loss of bmal1 expression alters adipose tissue hormones, gene expression and glucose metabolism. PLoS ONE 2013, 8:e65255.
117. Turek F.W., et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005, 308:1043-1045.
118. Oishi K., et al. Disrupted fat absorption attenuates obesity induced by a high-fat diet in Clock mutant mice. FEBS Lett. 2006, 580:127-130.
119. Kudo T., et al. Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet. J. Biol. Rhythms 2007, 22:312-323.
120. Kennaway D.J., et al. Metabolic homeostasis in mice with disrupted Clock gene expression in peripheral tissues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1528-R1537.
121. Shostak A., et al. Circadian regulation of lipid mobilization in white adipose tissues. Diabetes 2013, 62:2195-2203.